scholarly journals The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication

2021 ◽  
pp. 100002
Author(s):  
Lauren M. Hamel ◽  
David W. Dougherty ◽  
Theresa A. Hastert ◽  
Erlene K. Seymour ◽  
Seongho Kim ◽  
...  
Healthcare ◽  
2021 ◽  
Vol 9 (9) ◽  
pp. 1120
Author(s):  
Aviad Tur-Sinai ◽  
Netta Bentur ◽  
Damien Urban

Honest communication between oncologists and patients is important in alleviating the financial burden of cancer care. This study explored patient–relative–oncologist communication regarding the affordability of out-of-pocket (OOP) medication and the extent to which this communication addresses itself to the families’ financial burden. A cross-sectional survey was conducted among primary caregivers of deceased cancer patients. About 43% of relatives said that they and/or the patients had paid out of pocket for medications during the last six months of the patient’s life. Most (73%) oncologists suggested an OOP medication without asking about financial ability, 43% hardly explained the advantages of an OOP medication, and 52% hardly explained any treatment alternatives. Older age and female gender were related to less communication about an OOP medication, and better education, greater affluence, and having private health insurance were related to more communication. About 56% of relatives said that OOP payment for medications inflicted a very heavy or heavy financial burden on patients and their households. Physicians’ interest in financial ability and giving explanation lightened the burden. Given the difficulty of explaining the complex interactions of cost and clinical outcomes, oncologists need to be better educated in skills that would enable them to communicate costs more openly and should consider the cost of a treatment when prescribing it.


2019 ◽  
Vol 24 (8) ◽  
pp. 1048-1055 ◽  
Author(s):  
Ryan D. Nipp ◽  
Hang Lee ◽  
Emily Gorton ◽  
Morgan Lichtenstein ◽  
Salome Kuchukhidze ◽  
...  

Cancer ◽  
2020 ◽  
Vol 126 (10) ◽  
pp. 2111-2112
Author(s):  
Carrie Printz

2017 ◽  
Vol 72 ◽  
pp. S118-S119
Author(s):  
E. Unal ◽  
T. Canbak ◽  
A. Acar ◽  
K.H. Tolan ◽  
S. Yuksekdag ◽  
...  

Author(s):  
Ryan D. Nipp ◽  
Ellen Miller Sonet ◽  
Gery P. Guy

In recent years, high health care costs and the financial burden of cancer care have received increased attention. In response to the financial burden of cancer care, patients may jeopardize their health outcomes by not properly adhering to prescribed therapies or even forgoing and delaying care in an effort to defray costs. In addition, the financial burden experienced by patients with cancer may negatively impact clinical outcomes, such as quality of life, physical and psychological symptoms, and potentially, even survival. Notably, in the current era of targeted treatment and immunotherapies for patients with cancer, the rising costs of cancer continue to remain at the forefront of patient concerns. Therefore, a critical need exists to determine how best to assist patients with the cost burden of cancer diagnosis and treatment


2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 6501-6501
Author(s):  
Ryan David Nipp ◽  
Daniel Finkelstein ◽  
Elizabeth Powell ◽  
Lisa Vittorio ◽  
Nicole Birrer ◽  
...  

2016 ◽  
Vol 21 (4) ◽  
pp. 467-474 ◽  
Author(s):  
Ryan D. Nipp ◽  
Hang Lee ◽  
Elizabeth Powell ◽  
Nicole E. Birrer ◽  
Emily Poles ◽  
...  

JAMA Oncology ◽  
2015 ◽  
Vol 1 (3) ◽  
pp. 273 ◽  
Author(s):  
Veena Shankaran ◽  
Scott Ramsey

Sign in / Sign up

Export Citation Format

Share Document